<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-551
Date of Submission: 2024-11-02

This report was submitted by a Patient from Patterson Inc Medical Center concerning patient ANON-PX-8015. The subject is an adult male with a significant medical history including migraines, asthma. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Gabapentin (Anticonvulsant) administered via the Subcutaneous route at a dosage of 51mg, initiated on 2024-10-01 for Neuropathic pain and discontinued on 2024-10-24.

On approximately 2024-10-13, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Diarrhea, Dizziness, Anaphylaxis. The Diarrhea was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed tree and advised phone. The current patient status regarding this symptom is 'Not Recovered'. The Dizziness was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovering'. The Anaphylaxis was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Rechallenge not performed'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: End north ability phone. All both author base. Different history instead political teach lot.</data>
report_id: ADR-2024-551
report_date: '2024-11-02'
patient_details:
  patient_id: ANON-PX-8015
  gender: Male
  relevant_history:
  - migraines
  - asthma
suspected_drugs:
- drug_name: Gabapentin
  dosage: 51mg
  route_of_administration: Subcutaneous
  start_date: '2024-10-01'
  indication_for_use: Neuropathic pain
  drug_class: Anticonvulsant
  end_date: '2024-10-24'
adverse_reactions:
- symptom_name: Diarrhea
  onset_date: '2024-10-13'
  severity: Mild
  outcome: Not Recovered
  intervention_required: true
  intervention_details: Prescribed tree and advised phone.
- symptom_name: Dizziness
  onset_date: '2024-10-13'
  severity: Life-threatening
  outcome: Recovering
  intervention_required: false
- symptom_name: Anaphylaxis
  onset_date: '2024-10-13'
  severity: Life-threatening
  outcome: Recovered
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Rechallenge not performed
reporting_facility: Patterson Inc Medical Center
reporter_type: Patient
notes: End north ability phone. All both author base. Different history instead political
  teach lot.
